Skip to the page

Data / Medical devices / Canada / Prollenium Medical Technologies Inc.

Prollenium Medical Technologies Inc.: FDA-registered device maker in Aurora Ontario, Canada, 1 PMA approval

Prollenium Medical Technologies Inc. is registered with the FDA (registration 3004423487) in Aurora Ontario, Canada. It lists 3 device types. The FDA files 1 PMA approval under its listings, the newest dated August 4, 2017. 1 recall event names it as the recalling firm. Registered through 2026. FDA data exported November 2, 2026.

SpecStream is the live web data engine for teams and agents. It reads the FDA registration and listing, 510(k), PMA, recall and enforcement files from openFDA every week, and this page is that reading, joined by the FDA's own numbers. Ask for the makers of any device type in any country and new clearances, approvals and recalls arrive in your sheet, CRM, Slack or agent as the FDA publishes them.

FDA registration number
3004423487
Address
138 Industrial Pkwy N., Aurora Ontario, Canada, L4G4C3
Owner or operator
Prollenium Medical Technologies Inc. (10055618)
Roles
Complaint file establishment, Exporter to the US, Foreign private label distributor, Manufacturer, Specification developer
First device listed
August 23, 2017
Registered through
2026
Brand names listed
Revanesse Gel Pack, Revanesse Versa, Revanesse Versa+ with Lidocaine, Revanesse Versa+ with Lidocaine 1.2 mL, Revanesse® Lips™ + with Lidocaine, Revanesse® Lips™ + with Lidocaine 1.2 mL, Revanesse® Versa™ 1.2 mL, SoftFil® EasyGuide and more

Devices it lists

DeviceProduct codeClassRoleSource
Cannula, Surgical, General & Plastic SurgeryGEA1Complaint file establishment, Exporter to the US, Foreign private label distributor, Specification developeraccessdata.fda.gov
Implant, Dermal, For Aesthetic UseLMH3Complaint file establishment, Manufactureraccessdata.fda.gov
Pack, Hot Or Cold, ReusableIME1Complaint file establishment, Exporter to the US, Foreign private label distributoraccessdata.fda.gov

PMA approvals

Premarket approvals this establishment lists, with the supplements the FDA has decided since.

ApprovedPMA numberDeviceProduct codeSupplementsLatest decisionSource
August 4, 2017P160042REVANESSE ULTRALMH24October 14, 2026accessdata.fda.gov

Recalls

Recall events where this establishment is the recalling firm, matched on its FEI.

InitiatedEventClassStatusProductReasonSource
November 15, 201883834Class IITerminatedRevanesse Versa, PN40081Labeling error. The product is labeled with an 18 month expiration date, however the product is approved for 12 months.accessdata.fda.gov

Compare with other makers

Updated October 14, 2026. Read from openFDA bulk downloads (device registration and listing, 510(k), PMA, recall and enforcement files). CC0 1.0, public domain (openFDA terms of service). The files are joined on FDA identifiers: the 510(k) and PMA numbers a registration lists, and the recalling firm's FEI for recalls. Recall class comes from the FDA enforcement report. The FDA states that openFDA data is unvalidated and is not for decisions about medical care. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.